Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 167

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Crosstalk between Advanced Glycation and Endoplasmic Reticulum Stress: Emerging Therapeutic Targeting for Metabolic Diseases

Piperi, Christina, Adamopoulos, Christos, Dalagiorgou, Georgia, Diamanti-Kandarakis, Evanthia, Papavassiliou, Athanasios G. · 2012 · The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: Advanced glycation, the major posttranslational modification of proteins, DNA, and lipids, is accelerated under conditions of increased oxidative stress, hyperglycemia, and hypoxia contributing to a variety of metabolic diseases such as diabetes mellitus, obesity, inflammation, polycystic ovarian syndrome, ischemic cardiovascular disease, and neurodegenerative disorders.The potential role of advanced glycation in endoplasmic reticulum (ER) homeostasis is largely unknown. Evidence Acquisition:Basic and clinical peer-reviewed articles on advanced glycation and ER stress related to metabolic regulation were searched in PubMed from 2000 -2011.The resulting articles as well as relevant cited references were reviewed. Evidence Synthesis:Recent evidence indicates that hyperglycemia, hypoxia, and oxidative stress, apart of triggering advanced glycation, can also adversely affect ER function, leading to pathogenic ER stress, followed by the unfolded protein response.The concomitant presence of advanced glycation in the same conditions with ER stress suggests their crosstalk in the progression of diseases associated with hypoxic and oxidative stress.Conclusion: Current data support the direct or indirect induction of ER stress response by advanced glycation end products or advanced glycation end product precursors in the pathogenesis of metabolic diseases.Inhibitors of advanced glycation acting as potent ER stress modulators with beneficial effects in restoring ER homeostasis and adjusting physiological unfolded protein response level present an emerging therapeutic approach with significant applications, especially in the context of metabolic dysfunction.(J Clin Endocrinol Metab 97: 2231-2242, 2012) I n the last century, an increased prevalence of chronic metabolic disorders including obesity, type 2 diabetes (T2D), and insulin resistance has been observed in developed countries, affecting adults as well as children (1, 2).Abnormal insulin action and increased adiposity are the hallmarks of numerous health problems associated with elevated incidence of T2D, hepatobilliary and gall bladder disorders, cardiovascular complications, neurodegenerative diseases, and tumors (3, 4).The underlying causative mechanisms usually involve dysregulation or lack of cooperation between homeostatic mechanisms implicated in nutrient and energy management.Metabolic dysregulation as characterized by high energy and excess nutrient intake is often associated to unbalanced glucose homeostasis and subsequent insulin secretion affecting a variety of organs, including pancreatic ␤-cells, liver, fat, and muscle tissue as well as brain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2011-3408

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 167

Metadata

Authors
Piperi, C., Adamopoulos, C., Dalagiorgou, G., Diamanti-Kandarakis, E., & Papavassiliou, A. G.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2012-07
Volume
97
Issue
7
Pages
2231-2242
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2021585578
Cited by
167
References
19
FWCI
8.08
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Crosstalk between Advanced Glycation and Endoplasmic Reticulum Stress: Emerging Therapeutic Targeting for Metabolic Diseases. https://app.cochat.ai/papers/10.1210/jc.2011-3408
The paper
Piperi, C., Adamopoulos, C., Dalagiorgou, G., Diamanti-Kandarakis, E., & Papavassiliou, A. G. (2012). Crosstalk between Advanced Glycation and Endoplasmic Reticulum Stress: Emerging Therapeutic Targeting for Metabolic Diseases. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2011-3408

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.